Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2001-02-23

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1006/BBRC.2001.4354PMID 11181068
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure‐activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens

  2001cited by this paper
• The Synthesis of N‐Vanillyl‐arachidonoyl‐amide (Arvanil) and Its Analogues: An Improved Procedure for the Synthesis of the Key Synthon Methyl 14‐Hydroxy‐(all‐cis)‐5,8,11‐tetradecatrienoate.

  2001cited by this paper
• Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells.

  2000cited by this paper
• Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.

  2000cited by this paper
• Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human.

  2000cited by this paper
• The Synthesis of N-Vanillyl-arachidonoyl-amide (Arvanil) and its Analogs: An Improved Procedure for the Synthesis of the Key Synthon Methyl 14-Hydroxy-(all-cis)-5,8,11-tetradecatrienoate

  2000cited by this paper
• Vanilloid receptors on capsaicin‐sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries

  2000cited by this paper
• Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin‐like activity

  2000cited by this paper
• New perspectives on enigmatic vanilloid receptors.

  2000cited by this paper
• Cloning and functional expression of a human orthologue of rat vanilloid receptor‐1

  2000cited by this paper
• The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

  2000cited by this paper
• Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice

  2000cited by this paper
• Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide.

  2000cited by this paper
• Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

  1999cited by this paper
• Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

  1999cited by this paper
• Anandamide and WIN 55212‐2 inhibit cyclic AMP formation through G‐protein‐coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes

  1999cited by this paper
• Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.

  1999cited by this paper
• Endocannabinoids.

  1998cited by this paper
• Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.

  1998cited by this paper
• Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.

  1998cited by this paper
• Pharmacology of cannabinoid CB1 and CB2 receptors.

  1997cited by this paper
• Potent anandamide analogs: the effect of changing the length and branching of the end pentyl chain.

  1997cited by this paper
• Accumulation of N‐Arachidonoylethanolamine (Anandamide) into Cerebellar Granule Cells Occurs via Facilitated Diffusion

  1997cited by this paper
• The capsaicin receptor: a heat-activated ion channel in the pain pathway

  1997cited by this paper
• (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability.

  1994cited by this paper
• Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

  1993cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper

• THC and CBD Induce Heme Oxygenase-1-Dependent Cell Death and Trigger Mitochondrial Dysfunction in Human Melanoma and Cutaneous Squamous Cell Carcinoma Cells

  2026cites this paper
• The Development and Therapeutic Potential of Classical and Next-Generation Cannabinoid Ligands.

  2025cites this paper
• Cannabinoid receptors in GtoPdb v.2025.1

  2025cites this paper
• The multicomponent Passerini reaction as a means of accessing diversity in structure, activity and properties: Soft and hard vanilloid/cannabinoid modulators.

  2024cites this paper
• Dynamic Mechanism for Subtype Selectivity of Endocannabinoids

  2024cites this paper
• A systematic review of novel cannabinoids and their targets: insights into the significance of structure in activity.

  2024cites this paper
• Cannabinoid receptors in GtoPdb v.2023.1

  2023cites this paper
• Impact of Cannabinoid Receptors in the Design of Therapeutic Agents against Human Ailments.

  2023cites this paper
• Phytocannabinoids as Potential Multitargeting Neuroprotectants in Alzheimer's Disease.

  2023cites this paper
• Potential of dietary hemp and cannabinoids to modulate immune response to enhance health and performance in animals: opportunities and challenges

  2023cites this paper
• Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual Modulators

  2022cites this paper
• The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization.

  2021cites this paper
• Non-opioid Analgesics and the Endocannabinoid System

  2020cites this paper
• Different Effects of Cannabis Abuse on Adolescent and Adult Brain

  2020cites this paper
• The endocannabinoid system – current implications for drug development

  2020cites this paper
• Binding Modes and Selectivity of Cannabinoid 1 (CB1) and Cannabinoid 2 (CB2) Receptor Ligands.

  2020cites this paper
• Modulation of Sensory Nerve Function by Insulin: Possible Relevance to Pain, Inflammation and Axon Growth

  2020cites this paper
• Cannabinoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Cannabinoids Stimulate the TRP Channel-Dependent Release of Both Serotonin and Dopamine to Modulate Behavior in C. elegans

  2019cites this paper
• Morphometric and neurochemical characterization of primary sensory neurons expressing the insulin receptor in the rat

  2019cites this paper
• Biotin conjugated organic molecules and proteins for cancer therapy: A review.

  2018cites this paper
• Capsaicin-induced activation and chemical injury of nociceptive primary sensory neurons: the role of gangliosides in the pain system

  2017cites this paper
• Capsaicin presynaptically inhibits glutamate release through the activation of TRPV1 and calcineurin in the hippocampus of rats.

  2017cites this paper
• Cannabis and cannabis resin pre-review report. A document prepared for the World Health Organization Expert Committee on Drug Dependence, Thirty-eight meeting Geneva, 14 – 18 November 2016.

  2016cites this paper
• Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.

  2015cites this paper
• Cannabis and Bioactive Cannabinoids

  2015cites this paper
• New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds

  2015cites this paper
• The effect of intra-ventral hippocampus administration of TRPV1 agonist and antagonist on spatial learning and memory in male rats

  2014cites this paper
• "Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays.

  2014cites this paper
• A Systems Pharmacology Perspective on the Clinical Development of Fatty Acid Amide Hydrolase Inhibitors for Pain

  2014cites this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cites this paper
• The role of the endocannabinoid system in fertility control

  2013cites this paper
• An investigation into the pharmacological effects of phytocannabinoids and endocannabinoids in human mesenteric arteries

  2013cites this paper
• THC-MEDIATED INDUCTION OF ΔFOSB AND ITS MODULATION OF CB1R SIGNALING AND ADAPTATION

  2013cites this paper
• The role of CB1 in immune modulation by cannabinoids.

  2013cites this paper
• Transient receptor potential channels - emerging novel drug targets for the treatment of pain.

  2013cites this paper
• Immunoregulation of experimental autoimmune encephalomyelitis by the selective CB1 receptor antagonist

  2012cites this paper
• Système endocannabinoïde et physiopathologie de l’obésité : rôle des CB1R (périphériques) du tissu adipeux et du foie

  2011cites this paper
• The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility.

  2011cites this paper
• Cannabinoids: potential targets for bladder dysfunction.

  2011cites this paper
• Dissimilar cannabinoid substitution patterns in mice trained to discriminate &Dgr;9-tetrahydrocannabinol or methanandamide from vehicle

  2011cites this paper
• Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.

  2011cites this paper
• Targeting CB(2) receptor as a neuroinflammatory modulator in experimental autoimmune encephalomyelitis.

  2011cites this paper
• Guide to Receptors and Channels (GRAC), 5th edition

  2011cites this paper
• Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.

  2010cites this paper
• Impact du système endocannabinoïdien sur la physiologie de l'obésité : effets de l'antagonisme des récepteurs CB1 sur le métabolisme glucido-lipidique de la souris obèse

  2010influential citation
• The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation.

  2010cites this paper
• Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugs.

  2010cites this paper
• Midcervical vagotomy precludes respiratory response to novel anti-inflammatory and anti-tumour drug arvanil in rats.

  2010cites this paper
• Cannabinoid receptors in the 3D reconstructed mouse brain: Function and regulation

  2010cites this paper
• Guide to Receptors and Channels (GRAC), 4th edition

  2009cites this paper
• Potential analgesic mechanisms of acetaminophen.

  2009cites this paper
• Deletion of vanilloid receptor (TRPV1) in mice alters behavioral effects of ethanol.

  2009cites this paper
• Latest advances in cannabinoid receptor agonists

  2009influential citation
• Pharmacological tools in endocannabinoid neurobiology.

  2009cites this paper
• Discriminative stimulus functions of methanandamide and ∆9-THC in rats: tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol

  2009cites this paper
• TRPV1 channels control synaptic plasticity in the developing superior colliculus

  2009cites this paper
• A Putative ‘Pre-Nervous’ Endocannabinoid System in Early Echinoderm Development

  2009cites this paper
• Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: Drug-discovery strategies

  2009cites this paper
• Endocannabinoids and Their Synthetic Analogs

  2009cites this paper
• Preclinical Pharmacological and Brain Bioassay Systems for CB1 Cannabinoid Receptors

  2009cites this paper
• Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain.

  2008cites this paper
• CB1 and CB2 receptor pharmacology

  2008cites this paper
• Endocannabinoid and serotonergic systems are needed for acetaminophen‐induced analgesia

  2008cites this paper
• Cannabinoids: A novel treatment strategy for retinal neurodegenerative disorders

  2008cites this paper
• Evaluation of fatty acid amides in the carrageenan-induced paw edema model.

  2008influential citation
• TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications.

  2008cites this paper
• Sensitivity to Δ9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2−/− mice

  2008cites this paper
• Role of VR1 and CB1 receptors in modelling of cardio-respiratory response to arvanil, an endocannabinoid and vanilloid hybrid, in rats.

  2008cites this paper
• Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond

  2008cites this paper
• Chapter 7 CB 1 and CB 2 Receptor Pharmacology

  2008cites this paper
• Endocannabinoids in the dentate gyrus.

  2007cites this paper
• Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology.

  2007cites this paper
• Guide to Receptors and Channels (GRAC), 2nd edition (2007 Revision).

  2007cites this paper
• Biochemistry and pharmacology of endovanilloids.

  2007cites this paper
• First “hybrid” ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non‐polyunsaturated fatty acid‐derived CB2‐selective ligands

  2006cites this paper
• UMEÅ UNIVERSITY MEDICAL DISSERTATIONS

  2006cites this paper
• New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis

  2006cites this paper
• The cannabinergic system as a target for anti-inflammatory therapies.

  2006cites this paper
• Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice.

  2006cites this paper
• Development of the first potential covalent inhibitors of anandamide cellular uptake.

  2006cites this paper
• Cannabinoid receptors as therapeutic targets.

  2006cites this paper
• The endocannabinoid and endovanilloid systems and their interactions in neuropathic pain

  2006cites this paper
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy

  2006influential citation
• In vitro and in vivo pharmacology of synthetic olivetol‐ or resorcinol‐derived cannabinoid receptor ligands

  2006cites this paper
• Further advances in the synthesis of endocannabinoid-related ligands

  2005cites this paper
• Natural cannabinoids: templates for drug discovery.

  2005cites this paper
• The biosynthesis, fate and pharmacological properties of endocannabinoids.

  2005cites this paper
• Pharmacological actions of cannabinoids.

  2005cites this paper
• Role of lipids and lipid signaling in the development of cannabinoid tolerance.

  2005cites this paper
• Membrane receptor probes: solid-phase synthesis of biotin-Asp-PEG-arvanil derivatives.

  2005cites this paper
• Pharmacology of Palmitoylethanolamide and Related Compounds

  2005cites this paper
• Structural requirements for cannabinoid receptor probes.

  2005cites this paper
• CB1 cannabinoid receptor ligands.

  2005cites this paper
• Behavioral effects of the novel cannabinoid full agonist AM 411.

  2005cites this paper
• Cannabinoids and Herpesviruses

  2005cites this paper
• Non-CB1, Non-CB2 Receptors for Endocannabinoids

  2005cites this paper
• The endocannabinoid signalling system: biochemical aspects.

  2005cites this paper
• The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.

  2005cites this paper
• Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice.

  2005cites this paper